CoChat

Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells

Open access
Goyal, Yogesh, Busch, Gianna T., Pillai, Maalavika, Li, Jingxin, Boe, Ryan H., Grody, Emanuelle I., Chelvanambi, Manoj, Dardani, Ian P., Emert, Benjamin, Bodkin, Nicholas, Braun, Jonas, Fingerman, Dylan, Kaur, Amanpreet, Jain, Naveen, Ravindran, Pavithran T., Mellis, Ian A., Kiani, Karun, Alicea, Gretchen M., Fane, Mitchell E., Ahmed, Syeda Subia, Li, Haiyin, Chen, Yeqing, Chai, Cedric, Kaster, Jessica, Witt, Russell G., Lazcano, Rossana, Ingram, Davis R., Johnson, Sarah B., Wani, Khalida, Dunagin, Margaret C., Lazar, Alexander J., Weeraratna, Ashani T., Wargo, Jennifer A., Herlyn, Meenhard, Raj, Arjun · 2023 · Nature
Cited by 184

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Anti-cancer treatment often results in a subset of the clonal cell population developing resistance to therapy, with resistant cells displaying a diversity of fate types resulting from the intrinsic variability among the clonal population before treatment. Even among genetically identical cancer cells, resistance to therapy frequently emerges from a small subset of those cells^ 1 – 7 . Molecular differences in rare individual cells in the initial population enable certain cells to become resistant to therapy^ 7 – 9 ; however, comparatively little is known about the variability in the resistance outcomes. Here we develop and apply FateMap, a framework that combines DNA barcoding with single-cell RNA sequencing, to reveal the fates of hundreds of thousands of clones exposed to anti-cancer therapies. We show that resistant clones emerging from single-cell-derived cancer cells adopt molecularly, morphologically and functionally distinct resistant types. These resistant types are largely predetermined by molecular differences between cells before drug addition and not by extrinsic factors. Changes in the dose and type of drug can switch the resistant type of an initial cell, resulting in the generation and elimination of certain resistant types. Samples from patients show evidence for the existence of these resistant types in a clinical context. We observed diversity in resistant types across several single-cell-derived cancer cell lines and cell types treated with a variety of drugs. The diversity of resistant types as a result of the variability in intrinsic cell states may be a generic feature of responses to external cues.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-023-06342-8

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 23 references

Cited by

See all 184

Metadata

Authors
Goyal, Y., Busch, G. T., Pillai, M., Li, J., Boe, R. H., Grody, E. I., Chelvanambi, M., Dardani, I. P., Emert, B., Bodkin, N., Braun, J., Fingerman, D., Kaur, A., Jain, N., Ravindran, P. T., Mellis, I. A., Kiani, K., Alicea, G. M., Fane, M. E., Ahmed, S. S., Li, H., Chen, Y., Chai, C., Kaster, J., Witt, R. G., Lazcano, R., Ingram, D. R., Johnson, S. B., Wani, K., Dunagin, M. C., Lazar, A. J., Weeraratna, A. T., Wargo, J. A., Herlyn, M., & Raj, A.
Venue
Nature
Published
2023-07-19
Volume
620
Issue
7974
Pages
651-659
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W4384819865
Cited by
184
References
23
FWCI
13.75
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. https://app.cochat.ai/papers/10.1038/s41586-023-06342-8
The paper
Goyal, Y., Busch, G. T., Pillai, M., Li, J., Boe, R. H., Grody, E. I., Chelvanambi, M., Dardani, I. P., Emert, B., Bodkin, N., Braun, J., Fingerman, D., Kaur, A., Jain, N., Ravindran, P. T., Mellis, I. A., Kiani, K., Alicea, G. M., Fane, M. E., . . . Raj, A. (2023). Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells. Nature. https://doi.org/10.1038/s41586-023-06342-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.